AzTrials
AzTrials

Mild Cognitive ImpairmentNCT06367231

SCGs as a Proxy for Determining the Cognitive Status of Older Adults

An observational study of Mild Cognitive Impairment and Dementia, run by University of Alberta at 8 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Detecting memory problems early is crucial for treating conditions like Mild Cognitive Impairment (MCI), which often leads to dementia. Currently, doctors use tests in clinics to check for these issues. However, there's a growing need for better methods to monitor our cognitive skills over time. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
What is being tested?
VibrantMinds
How many people
6 participants
Where
8 sitesCanada
Study dates
1 May 2024to 1 May 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: Older healthy adults (cognitively intact) Older adults with Mild Cognitive Impairment Older adults with Dementia

Who may be able to join

  • Reside in Calgary and/or Edmonton, Alberta, Canada
  • sufficient English language skills to converse in English with research staff

Who cannot join

  • Moderate or severe limitations in the control or movement of the upper extremity (e.g., severe arthritis, amyotrophic lateral sclerosis, multiple sclerosis)
  • Visual and hearing impairments
  • Attention deficit

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

Canada8 sites
  • Alzheimer Society of Alberta and Northwest Territories

    Edmonton, Alberta, T6H 2J3

  • CapitalCare Corporate Services

    Edmonton, Alberta

  • Edmonton Life Long Learners

    Edmonton, Alberta

  • Institute for Continuing Care Education and Research

    Edmonton, Alberta

  • Shepherd's Care Foundation

    Edmonton, Alberta

  • St. Michael's Long Term Care Centre,

    Edmonton, Alberta

  • Sherwood Care

    Sherwood Park, Alberta

  • Tofield Health Centre

    Tofield, Alberta

Other trials in Canada

About this study

Official title: Serious Computer Games as a Proxy for Determining the Cognitive Status of Older Adults

Detecting memory problems early is crucial for treating conditions like Mild Cognitive Impairment (MCI), which often leads to dementia. Currently, doctors use tests in clinics to check for these issues. However, there's a growing need for better methods to monitor our cognitive skills over time. Computer games emerge as a cost-effective solution for assessing the brain functions of older adults.

In our study, we are investigating the potential of computer games to reflect the cognitive skills of older adults. We developed the VibrantMinds platform, featuring five games: Whack-a-Mole, Bejeweled, Mahjong Solitaire, Word Search, and Memory Game. We have evaluated these games for ease of use, enjoyment, and their impact on brain functions. Now, our goal is to determine whether these games can offer valuable insights into the cognitive skills of older adults.

We are collecting demographic data, game-playing data, and cognitive test results. Our analysis will determine the correlation between game data, cognitive test outcomes, and demographic information. Additionally, we will assess both the perceived and observed engagement of older adults as they play the games.

Being tested
VibrantMinds
Keywords
Serious computer game, computer games, VibrantMinds
Medical subject headings
Cognitive Dysfunction, Dementia, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VibrantMindsOther

    Also called Serious Computer Games

    We are exploring the potential of computer games to reveal insights into the cognitive abilities of older adults. We developed the VibrantMinds (https://vibrant-minds.org/vibrantminds2/start) platform, featuring five games: Whack-a-Mole, Bejeweled, Mahjong Solitaire, Word Search, and Memory Game. Our evaluation focused on the usability of these games, their appeal to users, and their effectiveness in enhancing cognitive functions. The next phase of our study aims to determine whether these games can offer meaningful data on the cognitive skills of older adults.

Study groups in NCT06367231
Study groupRoleWhat they receive
Serious Computer Game InterventionOlder Adults (healthy), Older adults with MCI, older adults with dementia Each participant will undergo three sessions, spaced one week apart. These sessions will take place either at locations that support the research team's activities or at the participants' homes, offering flexibility to accommodate individual circumstances. The format of these sessions can vary, being either group-based or individual. Each session is designed to last approximately one hour, with a maximum duration of 90 minutes to ensure thoroughness without overwhelming participants.
Receives: Other: VibrantMinds

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognition - Global

    The Montreal Cognitive Assessment (MoCA) is a brief 30-point test used to screen for cognitive dysfunction in areas including memory, language, visuospatial skills, executive functions, attention, concentration, and orientation. A score of 26 or above is considered normal. Lower scores suggest potential cognitive impairment.

    Measured: At each session (3 sessions total, once per week, one week apart)

Secondary outcomes (4)
  1. Cognition - Global

    The Mini-Mental State Examination (MMSE) is a widely used 30-point questionnaire that assesses cognitive function, including orientation, recall, attention, calculation, language, and basic motor skills. A score of 24 or above typically indicates normal cognitive function, while lower scores suggest possible impairment.

    Measured: At each session (3 sessions total, once per week, one week apart)

  2. Cognition - Executive Function

    Trail Making Test, Part A and B. The norms and average completion times for the Trail Making Test (TMT) Parts A and B can vary significantly based on age, education, and the specific population being tested. However, general guidelines can provide some insight:

    TMT Part A: Average completion times for adults can range from 20 to 40 seconds. Younger adults and those with higher levels of education tend to complete Part A more quickly. Completion times increase with age.

    TMT Part B: This part is more complex and typically takes longer to complete, with average times ranging from 50 to 120 seconds.

    Measured: At each session (3 sessions total, once per week, one week apart)

  3. Game Performance

    Level, Accuracy, Time

    Measured: Obtained during each game (game played at each session, once per week, one week apart)

  4. Game Engagement

    Self-reported questionnaire of engagement and engagement indicators

    Measured: At each session (3 sessions total, once per week, one week apart)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2024
  2. Study start1 May 2024
  3. Primary completion1 May 2025
  4. Study completion1 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06367231
Sponsor's protocol ID
Pro00134554
Status last verified
Aug 2025
First submitted
23 Mar 2024
Last updated
8 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Mild Cognitive Impairment and Dementia, run by University of Alberta at 8 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognition - Global (time frame: At each session (3 sessions total, once per week, one week apart)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in